Purpose: To evaluate the effect of 3% trehalose as an adjuvant in the standard treatment after laser-assisted in situ keratomileusis.
Design: Interventional prospective comparative single-blind study.
Setting: Department of Ophthalmology, Hospital Quirón Zaragoza, Spain.